VIR
Vir Biotechnology Inc
10.70$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +536.1% | +235.8% | -94.5% | -22.6% | +419.9% | -75.5% | -60.0% | -80.2% | +26,595.8% | -100.0% | – | – | |
| – | -26.7% | -7.4% | +6.7% | +85.6% | -54.5% | +32.5% | -17.1% | +55.3% | -342.0% | – | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -100.7% | – | – | |
| – | -24.9% | -8.1% | +5.0% | +85.7% | -45.6% | +11.8% | -17.8% | +55.3% | -41.7% | +23.3% | +24.2% | – | |
| – | +4.9% | -15.8% | -16.6% | -14.9% | +3.7% | -10.3% | -6.9% | -0.2% | +6.2% | -1.2% | +29.4% | – | |
| – | +11.6% | -23.3% | +49.1% | -32.0% | +5.9% | -38.7% | -11.4% | +0.5% | +2,001.8% | -72.1% | +27.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -647.8% | – | -148.6% | – | +962.5% | -1.2% | -181.5% | – | +5.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.